Pharmaceutical manufacturing

Signs posted on the door of the Luscious Salon advises customers about the pandemic guidelines followed, Lodi, Calif., Wednesday, Dec. 9, 2020. Lodi, a city of just under 68,000 people, is part of the San Joaquin Valley region. The coronavirus is spreading rapidly in California's San Joaquin Valley and filling its hospitals. It has the fewest available intensive care unit beds of any region in California, a frightening reality that health officials hope will convince more people to wear masks and socially distance. (AP Photo/Rich Pedroncelli)
December 12, 2020 - 7:48 pm
BALTIMORE — The U.S. has recorded more than 16 million cases of COVID-19, by far the most of any country in the world, according to data kept by Johns Hopkins University. Cases of the virus have been rising across much of the U.S., causing record death totals in recent days. India and Brazil are...
Read More
The Pfizer Global Supply Kalamazoo manufacturing plant is shown in Portage, Mich., Friday, Dec. 11, 2020. The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans. (AP Photo/Paul Sancya)
Associated Press
December 12, 2020 - 10:58 am
WASHINGTON (AP) — The nation's first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans. Trucks will roll out Sunday morning as...
Read More
FILE - In this Jan. 29, 2009 file photo, reflections are seen on a sign outside the global headquarters of AstraZeneca in London. Cambridge, England-based pharmaceutical company AstraZeneca, which is involved in development of a COVID-19 vaccine, said Saturday Dec, 12, 2020, it is acquiring Boston-based drug developer Alexion Pharmaceuticals Inc. in a deal worth dollars 39 billion. (AP Photo/Kirsty Wigglesworth, File)
December 12, 2020 - 6:42 am
LONDON (AP) — Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said Saturday it's using a combination of cash and shares for...
Read More
President Donald Trump speaks during an "Operation Warp Speed Vaccine Summit" on the White House complex, Tuesday, Dec. 8, 2020, in Washington. (AP Photo/Evan Vucci)
December 11, 2020 - 9:22 pm
WASHINGTON (AP) — President Donald Trump has been highlighting lots of really big numbers this week: New highs for the stock market. The 100-plus House members backing a lawsuit challenging his election loss. The nearly 75 million people who voted for him. All the while, he's looked past other...
Read More
President Donald Trump speaks during an "Operation Warp Speed Vaccine Summit" on the White House complex, Tuesday, Dec. 8, 2020, in Washington. (AP Photo/Evan Vucci)
December 11, 2020 - 8:11 pm
WASHINGTON (AP) — President Donald Trump has been highlighting lots of really big numbers this week: New highs for the stock market. The 100-plus House members backing a lawsuit challenging his election loss. The nearly 75 million people who voted for him. All the while, he's looked past other...
Read More
FILE - In this Sept. 23, 2020, file photo, Dr. Stephen Hahn, commissioner of the U.S. Food and Drug Administration, testifies during a Senate Senate Health, Education, Labor, and Pensions Committee Hearing on the federal government response to COVID-19 on Capitol Hill. White House chief of staff Mark Meadows has pressed Hahn to grant an emergency use authorization for Pfizer’s coronavirus vaccine by the end of the day on Dec. 11 .(Graeme Jennings/Pool via AP, File)
December 11, 2020 - 4:17 pm
WASHINGTON (AP) — White House chief of staff Mark Meadows on Friday pressed Food and Drug Administration chief Stephen Hahn to grant an emergency use authorization for Pfizer's coronavirus vaccine by the end of the day or face possible firing, two administration officials said. The vaccine produced...
Read More
In this photo provided by the New York Stock Exchange, traders Edward McCarthy, left, and Robert Charmak work on the floor during the Delwinds Insurance Acquisition Corp. IPO, Friday Dec. 11, 2020. U.S. stocks fell in morning trading Friday as prospects for another aid package from Washington faded while a surge in virus cases threatens to inflict more damage on an already battered economy. (Colin Ziemer/New York Stock Exchange via AP)
December 11, 2020 - 1:06 pm
Stocks ended lower on Wall Street as prospects for another aid package from Washington faded even as a surge in virus cases threatens to inflict more damage on an already battered economy. The S&P 500 fell 0.1% Friday, further backing off the record high it set on Tuesday. The benchmark index...
Read More
This photo taken taken Monday Nov.30, 2020 shows the logo of French drug maker Sanofi at the company's headquarters, in Paris. Drugmakers GlaxoSmithKline and Sanofi say their potential COVID-19 vaccine won't be ready until late next year as they seek to improve the shot's effectiveness in older people. The companies said Friday that early-stage trials showed the vaccine produced an "insufficient" immune response in older adults, demonstrating the need to refine the product so it protects people of all ages (AP Photo/Thibault Camus)
December 11, 2020 - 3:36 am
LONDON (AP) — Drugmakers GlaxoSmithKline and Sanofi said Friday that their potential COVID-19 vaccine won’t be ready until late next year because they need to improve the shot’s effectiveness in older people. The companies said early trials showed the vaccine produced an “insufficient” immune...
Read More
In this undated photograph, employees at the Serum Institute of India, the world’s largest manufacturer of vaccines, work at their facility in Pune, India. The Institute is further increasing its capacity for the coronavirus: from being able to make 1.5 billion shots in a year right now, to over 2.5 billion doses by the end of 2021. In a telephonic interview with the Associated Press, Chief Executive Adar Poonawalla, 39, said that he anticipates more viruses jumping from animal to human host. He said that the added capacity would be very useful in coming decades. (Serum Institute of India via AP)
December 11, 2020 - 12:50 am
NEW DELHI (AP) — The coronavirus pandemic is a “wake up call” for governments to invest more in health care, says Adar Poonawalla, CEO of the Serum Institute of India, the world’s largest manufacturer of vaccines. The Serum Institute has taken on a vital role as the largest company licensed to...
Read More
Registered nurse Laura Moore, left, swabs a patient during testing for COVID-19 organized by Philadelphia FIGHT Community Health Centers at Mifflin Square Park, Thursday, Dec. 10, 2020, in south Philadelphia. (AP Photo/Matt Slocum)
December 10, 2020 - 1:31 pm
TORONTO — Canada’s most populous province will begin administering COVID-19 vaccinations at hospitals in Toronto and Ottawa on Tuesday. Ontario Premier Doug Ford says a small number of doses are expected to arrive in the province in the coming days. Canada’s health regulator approved the vaccine by...
Read More

Pages